Thomson Reuters today announced the release of Micromedex 2.0, the newest version of its market-leading clinical information system.
Pharmacists, nurses, and physicians in more than 3,500 hospitals in 83 countries use Micromedex, which provides evidence-based information on drugs, disease management, toxicology, neonatal dosing, alternative medicines, and patient education.
The new version gives clinicians the same content that has made Micromedex the market leader over the last 30 years -- along with significant user interface and search modifications that improve the way they access and use the information. New features include an interface based on clinician workflow patterns, enhanced search capabilities, special tabs for high-usage tools, and compatibility with iPhone®, iPod® Touch, BlackBerry® smartphones, and other mobile devices.
Micromedex 2.0 will be available to all current customers at no additional charge beginning January 21, 2010.
Built using an iterative design process that involved more than 60 clinician-user interviews, Micromedex 2.0 offers several improvements over previous versions and competing solutions: